Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Foundation Elects Howard D. Morgan Chairman of the Board

MIAMI & NEW YORK — June 26, 2018 — The Parkinson’s Foundation today announced the election of Howard D. Morgan as chairman of its board of directors. Mr. Morgan, who previously served as the Vice Chair of the nonprofit organization’s board, is a Partner and the Senior Managing Director of Argand Partners in New York.

“Parkinson’s Foundation gains an impassioned and proven leader with Howard Morgan as Chairman who will ensure we further our mission to make life better for people with Parkinson’s disease,” said outgoing board chairman John W. Kozyak, Esq., who will remain on the board. “Howard’s appointment marks a new chapter for the Foundation, which has been on a strong growth trajectory over the last few years. That is expected to accelerate with Howard as chairman of the board.”

Mr. Morgan, who has been active in private equity for more than 30 years, also has served as a board member of more than 20 businesses in the U.S., Europe and Australia. He currently serves on the boards of Industrea Acquisition Corp.; Oase Living Water; Harvard Business School Club of New York; Alexander Hamilton Institute; World Press Institute; and Friends of the Garvan Institute of Medical Research.

“I am honored to further my commitment to the Parkinson’s community and the Foundation by building on the success of my predecessor John Kozyak during his tenure as chairman of the Parkinson’s Foundation,” Morgan said. “The Foundation’s mission is personal for me, as my father lived with the disease for many years.  I look forward to working with Andrew Albert as Vice Chair and the board to ensure a better life for everyone with Parkinson’s through investments in innovative research, improved clinical care, and expanded educational resources.”

Added Parkinson’s Foundation President and CEO John Lehr: “Howard is a proven leader with extensive business knowledge and experience.  He has been an invaluable contributor to our board for more than a decade, working closely with John Kozyak and other board members to position the Foundation for its current phase of rapid growth. We are thrilled Howard is taking on this critical role as the Foundation expands its mission programs for greater impact on all those living with and affected by Parkinson’s disease.”

Established in 1957, the Parkinson’s Foundation has headquarters in New York and Miami with more than 100 staff members across the country and has an annual budget of $30 million. In addition to supporting Parkinson’s research and patient and caregiver education, the Foundation has a national and international network of over 40 Parkinson’s Centers of Excellence at hospitals and academic medical institutions, where medical teams who specialize in Parkinson’s disease work together to treat and set the highest standards of care for people living with Parkinson’s.

Officers of the 27-person board are effective July 1, 2018: Howard D. Morgan, Chair; Andrew B. Albert, Vice Chair; Constance W. Atwell, PhD, Secretary; Curt DeGreff, Assistant Secretary; Stephen Ackerman, Treasurer; J. Gordon Beckham, Jr., Assistant Treasurer; Kelly Sweeney, Chair, People with Parkinson’s Advisory Council. A complete list of the Parkinson’s Foundation’s board of directors is available at www.parkinson.org/board.

About the Parkinson’s Foundation 
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).

About Parkinson’s Disease 
Affecting nearly one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the United States alone.

 
Tuesday, June 26, 2018
Update on NUPLAZID — FDA finds no new or unexpected safety risks
Friday, September 21, 2018

On September 20, 2018, the U.S. Food and Drug Administration (FDA) issued a review on the drug NUPLAZID (pimavanserin), a medication used to treat patients with hallucinations and delusions associated with Parkinson’s Disease psychosis.

According to the FDA website:

Parkinson’s Foundation Extends Bilingual National Helpline Hours
Tuesday, September 18, 2018

NEW YORK & MIAMI — September 18, 2018 — The Parkinson’s Foundation announced today that its toll-free Helpline, 1-800-4PD-INFO, will extend its hours, answering calls in English and Spanish, to help make life better for people with Parkinson’s disease (PD) and their families.

Parkinson’s Foundation Hosts Allied Team Training for Parkinson’s in Atlanta
Tuesday, September 11, 2018

NEW YORK & MIAMI—September 11, 2018—The Parkinson’s Foundation today announced the location of its signature professional education program course, Allied Team Training for Parkinson’s, ATTP®, for health care professionals treating patients with Parkinson’s disease, in Atlanta.

Parkinson’s Foundation Increases Funding to $6.2 Million to Advance Parkinson’s Research
Tuesday, August 14, 2018

NEW YORK & MIAMI — August 14, 2018 — The Parkinson’s Foundation announced today an increased investment of $6.2 million across 53 research grants to support the work of promising scientists in the field of Parkinson's disease (PD) in 2018.

PD Gladiators Merges with the Parkinson’s Foundation Expanding Reach in Greater Atlanta Parkinson’s Community
Wednesday, August 1, 2018

ATLANTA – August 1, 2018—PD Gladiators, Inc., an Atlanta-based nonprofit organization focused on combatting Parkinson’s disease (PD) with vigorous exercise, has merged with the Parkinson’s Foundation (PF), a non-profit organization whose mission is to make life better for people with PD worldwide through expert care and research.

Parkinson’s Foundation Partners with Medscape Education to Deliver Patient Education
Monday, July 30, 2018

July 30, 2018—The Parkinson’s Foundation has collaborated with Medscape Education to launch an online learning program entitled “Parkinson’s Disease Psychosis: A Learning Destination for Care Partners and Patients,” available on Medscape’s patient portal, WebMD Education.

Parkinson’s Foundation Designates Three Centers of Excellence in Parkinson’s Care: Global Network Expands to 45 Parkinson’s Centers
Tuesday, July 24, 2018

MIAMI & NEW YORK CITY — July 24, 2018 — The Parkinson’s Foundation today announced the addition of three new Centers of Excellence to its global network: Cleveland Clinic; Medical University of South Carolina; and University of Iowa Hospitals and Clinics.

Parkinson’s Foundation Funds $450,000 for Local Parkinson’s Programs in Seven Cities Across the Country
Monday, July 23, 2018

NEW YORK & MIAMI — July 23, 2018 — The Parkinson's Foundation today announced it will fund nearly $450,000 to local community grants in seven cities that hosted the Foundation's annual fundraiser, Moving Day, A Walk for Parkinson's, in 2017. These grants will further the health, wellness and education of people with Parkinson's disease (PD).

In Memory of Robert Traurig
Wednesday, July 18, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member Robert (Bob) Traurig. From 2004 to 2015, he was a member of the Foundation’s board of directors. Bob is survived by his wife Jacqueline, his daughters Madeline Sackel and Wendy Traurig.

New Study Shows 1.2 Million People in the United States Estimated to be Living with Parkinson’s Disease by 2030
Tuesday, July 10, 2018

Parkinson’s Foundation Reveals Most Comprehensive Estimate of
Parkinson’s Prevalence in North America since the 1970’s

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.